The TELICAST study by Johnston and colleagues showed that patients with asthma exacerbations that were given telithromycin, a ketolide, had an increase in symptom-free days and lung function tests conducted in the clinic compared with control subjects given placebo, but did not have an increase in lung function tests conducted at home (57) .